Loading...
Loading...
Classifies COPD severity based on post-bronchodilator spirometry (FEV1/FVC and FEV1 % predicted) and integrates exacerbation history and symptom burden (CAT/mMRC) to assign GOLD ABE groups for guiding pharmacologic therapy.
GOLD Spirometric Grade — Post-Bronchodilator FEV1 % Predicted (requires FEV1/FVC < 0.70 confirmed)
Symptom Burden — CAT or mMRC Score
Exacerbation History (past 12 months)
Awaiting input
Fill in the parameters to see your result